Trial ID or NCT#



recruiting iconRECRUITING


The purpose of this study is to prospectively analyze the value of 3D ultrasound perfusion imaging for treatment planning, the prediction of therapy success, and to monitor the treatment response in patients with a primary or metastatic liver tumor undergoing radiation treatment.

Official Title

Feasibility of 3D Perfusion Ultrasound for Liver Cancer SABR Planning and Response Evaluation

Eligibility Criteria

Ages Eligible for Study: Older than 18 Years
Sexes Eligible for Study: All
Accepts Healthy Volunteers: No


Dimitre Hristov
Aya Kamaya, MD
Aya Kamaya, MD
Professor of Radiology (Body Imaging)
Daniel Chang
Daniel Chang
Radiation oncologist
Member, Bio-X

Contact us to find out if this trial is right for you.


Jen-Yeu Wang
(650) 723-3110